Enter assignee name

EPO Patents = 5

Trademarks = 3

Forward Citations = 17

Loading Chart...

7 inventors (with patents filed for the assignee):

Wolfgang J Wrasidlo (12 out of 50 patents)

Emily M Stocking (8 out of 21 patents)

Srinivasa Reddy Natala (5 out of 12 patents)

4. Diana Luz Price (3 out of 3 patents)

5. Edward Rockenstein (1 out of 14 patents)

6. Eliezer Masliah (1 out of 15 patents)

7. Igor Flint Tsigelny (1 out of 3 patents)

12 patents: Sort by Forward Citations

1. 12049462 - Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways (2024-07-30),

2. 11708338 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2023-07-25),

3. 11492348 - Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways (2022-11-08),

4. 11345713 - Compounds as modulators of TLR2 signaling (2022-05-31),

5. 11299487 - Compounds and compositions as modulators of TLR signaling (2022-04-12),

6. 11236079 - Morpholine derivates as inhibitors of Vps34 (2022-02-01),

7. 11008294 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2021-05-18),

8. 10501423 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2019-12-10),

9. 9738635 - Heteroaryl amides as inhibitors of protein aggregation (2017-08-22),

10. 9527852 - Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation (2016-12-27),

11. 9284309 - Di- and tri-heteroaryl derivatives as inhibitors of protein aggregation (2016-03-15),

12. 8846682 - Compound suitable for the treatment of synucleopathies (2014-09-30),

Neuropore Therapies, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases. With a mission to improve the lives of patients suffering from disorders such as Parkinson's disease and Alzheimer's disease, Neuropore Therapies conducts cutting-edge research and clinical trials to discover and advance novel therapeutics. Their team of dedicated scientists, physicians, and industry experts work tirelessly to identify targets and develop breakthrough treatments that aim to slow or halt disease progression. Through collaboration and technological advancements, Neuropore Therapies strives to bring hope and better outcomes to patients and their families.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

12 Patents

#423 in San Diego, CA

#5,886 in California

#24,841 in US

#46,762 in the World

San Diego, CA, United States of America

Neuropore Therapies, Inc.